Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NeuroStar Advanced Therapy System (All previously cleared models)

K-Number: K231926 · 2024-03-22

ApplicantNeuronetics, Inc.
Decision Date2024-03-22
Product CodeOBP
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

NeuroStar Advanced Therapy System (All previously cleared models) is the device name listed in this FDA 510(k) record. The listed applicant is Neuronetics, Inc.. It received FDA 510(k) clearance on 2024-03-22 under 510(k) number K231926. The device is classified under product code OBP. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NeuroStar Advanced Therapy System (All previously cleared models)?

NeuroStar Advanced Therapy System (All previously cleared models) is a medical device that received FDA 510(k) clearance on 2024-03-22. The listed applicant is Neuronetics, Inc.. The 510(k) number is K231926.

When did NeuroStar Advanced Therapy System (All previously cleared models) receive FDA 510(k) clearance?

NeuroStar Advanced Therapy System (All previously cleared models) received FDA 510(k) clearance on 2024-03-22, under 510(k) number K231926.

Who is the listed applicant for NeuroStar Advanced Therapy System (All previously cleared models)?

The FDA 510(k) record lists Neuronetics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NeuroStar Advanced Therapy System (All previously cleared models)?

The FDA product code for NeuroStar Advanced Therapy System (All previously cleared models) is OBP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT06429748Symptom Evaluation Following Repetitive Transcranial Magnetic StimulationACTIVE_NOT_RECRUITINGNCT07147218Accelerated TMS for MDDACTIVE_NOT_RECRUITING

Other records listing Neuronetics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K233621NeuroStar Advanced Therapy System (Version 3.8)K231350OCD MT Cap (85-00397-000)K230029NeuroStar Advanced Therapy System (Version 3.7)K222230NeuroStar, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar Advanced Therapy System for Mental HealthK220127NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar Advanced Therapy for Mental HealthK212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar

View all 11 devices →

Related Devices (Code: OBP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261228QuickVision Ultimate rTMSBrain Ultimate, Inc.K260560Apollo TMS Therapy System;Apollo light TMS Therapy SystemMag & More GmbHK260189MagVenture Accelerated TMS (aTMS) Therapy SystemTonica Elektronik A/SK253098Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim OyjK252358Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim OyjK251653SPRY TMS Therapy System (0550)Soterix Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑